April 2, 2014

On April 1, 2014, President Obama signed into the Protecting Access to Medicare Act of 2014. This new law prevents a scheduled payment reduction for physicians and other practitioners who treat Medicare patients from taking effect on April 1, 2014. This new law maintains the 0.5 percent update for such services that applied from January 1, 2014 through March 31, 2014 for the period April 1, 2014 through December 31, 2014. It also provides a zero percent update to the 2015 Medicare Physician Fee Schedule (MPFS) through March 31, 2015. Read more >

 

 

March 31, 2014

EHR Incentive Payments Rise 3.6% in Feburary, Top $21.6B Overall

More than 94% of the 5,011 eligible U.S. Hospitals have registered for federal electronic health-record incentive payment programs under Medicare, Medicaid or both, while slightly more than 90% of those hospitals have shared in nearly $14.2 billion in EHR incentive payments, according to the latest federal data. 

The programs, created under the American Recovery and Reinvestment Act of 2009, also have enrolled more than 88% of the estimated 527,200 eligible physicians and other professionals, of whom two thirds have been paid a total of nearly $7.5 billion.

About $4.4 billion has been paid to physicians and other EPs under Medicare, about 59.4% of total expenditures for them; $2.7 billion under Medicaid (36.3%), and $315.7 million (4.2%) under Medicare Advantage.

Physicians and other EPs, unlike hospitals, must partcipate in either the Medicare, Medicaid or Medicare Advantage incentive programs, but not more than one.

Since the cash began to flow in january 2011, the total public spending under all EHR incentive programs is now reported $21.6 billion, according the the monthly report from CMS for February.

That is roughly $675 million, or 3.2% from the January report.

 

Click here for the Physician Quality Reporting System and Electronic Prescribing (eRx) Incentive Program Report published by CMS

Read more>

 

 

Portland Monthly Magazine just released it's Top Doctors issue, naming the highest ranking physicians in the Portland-Metro area, as voted on by their peers.

Practice Wise is proud to announce that two of our very own Aprima-using Doctors made this list!

Congratulations to Dr. Margaret McCloskey of Sunset Pediatrics in Portland, Oregon. Learn more about Dr. McCloskey and sunset pediatrics here!

Another big congratulations to Dr. Michael Pfister of Interventional and Vascular Consultants in Tualatin, Oregon. This is actually Dr. Pfister's second year in a row receiving this recognition. Furthermore, Interventional and Vascular Consultants opened up their second location this year at Montgomery Park in Portland, Oregon. To learn more about Dr. Pfister and Interventional and Vascular Consultants, click here!

 

We are prould to work with such great doctors. Way to go!

 

 

Aprima's EHR solution certified by InfoGard continues Aprima's long history of meeting each and every EHR certification.

Aprima Medical Software announced August 6th, 2013 that the company's EHR solution, Aprima PRM 2014 EHR (electronic health record) and PM (practice management), version 14.0, has received Meaningful Use Stage 2 certification as a Complete EHR for use in ambulatory care settings from InfoGard, an accredited ONC-ACT certification body.

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee receipt of incentive payments. Certification was received on August 5th, 2013 and the certification # is IG-2999-13-0024. Click here to see the Ambulatory Clinical Quality Measures that have been certified, as well as information about additional software required.

Aprima is one of the earliest achievers of Complete Meaningful Use Stage 2 compliance - an arduous process that required the company's EHR software to successfully pass hundreds of rigorous and detailed tests.

Meaningful Use Stage 2 brings many changes, including higher thresholds of utilization compared to Stage 1, expanded Clinical Quality Measures, and exciting new data exchange enhancements that will allow Aprima providers to seamlessly communicate clinical information with other products serving the healthcare industry. For example, when a provider needs to refer a patient outside their care, the system will be able to automatically generate a referral document to the referring provider.

Aprima also continues to take the standard requirements for certification and implement them in ways that save even more time for providers, by mimicking real-world daily workflows. For example, users now have an easy way to view a real-time dashboard that shows current Meaningful Use status and clinical quality measures. Unlike many other systems requiring overnight batching and updating, or reporting weeks or even months after the fact, Aprima's Meaningful Use dashboard is real-time and can even be run based on specific timeframes.

As with Stage 1, Aprima expects it will continue to hear from customers how easy it is to achieve Meaningful Use Stage 2 compared with other vendors. In addition to the product's intelligent navigation and general simplicity of use, Aprima's Meaningful Use dashboard allows users to accurately track progress for each quality measurement including a real time drill down for capability for quick and easy identification of patient's charts in and out of compliance

"We expect Meaningful Use Stage 2 certification will further distinguish the top-tier EHR companies from the rest of the pack. In fact, we're already seeing products being closed down." said Aprima CEO and president, Michael Nissenbaum. "Last Fall, Allscripts announced that it had opted not to develop or update its Allscripts MyWay product to be in compliance with government incentives and requirements such as Stage 2 Meaningful Use, 5010 and ICD-10."

He added, "For any providers who are concerned about their current vendor's ability to meet Meaningful Use Stage 2, or who have already found themselves without a solution going forward, now is the time to take a look at Aprima. And for those customers of Allscripts MyWay who may still be undecided, the Aprima Rescue Plan for Customers of Allscripts MyWay - offering a free license and database upgrade - still stands. Over 1,100 former customers of Allscripts MyWay have already made the decision to move to Aprima."

For more information about using the Aprima EHR to meet Meaningful Use Stage 2, ICD-10 readiness and controlled substances e-prescribing requirements, call Practice Wise at 503-582-8283, or email This email address is being protected from spambots. You need JavaScript enabled to view it..

 

 

Practice Wise  Offers  a LIFELINE to Allscripts MyWay Customers!

Allscripts™ has just announced that it has stopped the sale and further development of its MyWay EHR Product.

Practice Wise, LLC, a premier reseller of Aprima PRM, is offering a rescue package for MyWay customers. Upgrading from MyWay to Aprima gives you the best solution with VIRTUALLY NO COST AND VIRTUALLY NO DOWNTIME TO UPGRADE. Aprima Medical Software wrote the original code for MyWay, so your upgrade will be seamless, the look and feel of the product will be familiar to you. Aprima has over 1,000 enhancements not available in MyWay, you will be amazed!

At Practice Wise, we provide a level of service and support unmatched in the medical software industry. Come see how we do it - Our Way!